open-angle glaucoma or ocular hypertension
Ophthalmology · 2006–2012
4decisions
4medicines
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| dorzolamide hydrochloride with timolol maleate Reduction of elevated intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension that is not adequately controlled with monotherapy. | Jul 2012 | Recommended with restriction | no section in document |
| brinzolamide with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are not adequately controlled with timolol… | Mar 2010 | Recommended with restriction | no section in document |
| bimatoprost with timolol maleate Reduction of elevated intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension who are not adequately controlled with other treatments. | Mar 2009 | Recommended with restriction | no section in document |
| travoprost with timolol maleate, eye drops Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension for whom single agent therapy provides insufficient… | Jul 2006 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.